“… after undertaking a balanced assessment of risks and benefits, the panel agreed with the professional witnesses that [the Applicant has] satisfactorily addressed [his] risk factors to a degree that they would be manageable in the less restrictive regime in open prison conditions and whilst [on periods of temporary release on licence] where [he] would be unescorted. [The Applicant’s] risk of abscond is assessed by the panel and all witnesses as not being heightened and the panel accepted that [he has] no doubt as to the lengthy period [he] would likely spend in custody if you chose to abscond. “The panel was of the opinion that a return to open conditions will test whether [the Applicant has] internalised the lessons [he has] learnt and can act upon them in conditions that are more realistic and where [he] will be exposed to external stimuli. [The Applicant] will also be tested in terms of [his] ability to comply and self-manage in less restrictive prison conditions. “[The Applicant] remain[s] on a script and [his] current prescription level is considered by professionals to be a protective factor in that it stops [him] from seeking illicit drugs from elsewhere. The panel heard evidence during the hearing that enquiries had been made with a limited number of open prisons and some will not accept someone on such a high dose and others may do so but only if the dose is reducing. The panel was hopeful that it would be recognised by open establishments that [the Applicant’s] current script is considered to be a protective factor and that [he] would be able to make such a move if the Secretary of State accepts the panel’s recommendation. However, the particular open prisons available to [his] or the acceptance policies that they operate were not factors within the remit of the panel or the Secretary of State’s referral to the panel.”
“The panel heard evidence during the hearing that enquiries had been made with a limited number of open prisons and some will not accept someone on such a high dose and others may do so but only if the dose is reducing.”